. Author manuscript; available in PMC: 2021 Jan 1.

Published in final edited form as: Cancer. 2019 Sep 24;126(1):165–173. doi: 10.1002/cncr.32509

Table 2.

Change in ISI and POMS-SF Score at Follow-Up Time Points for STEP-1 (Sleep Education) and STEP-2 (Group CBT-I)

	Baseline		4 Week Follow-Up			8 Week Follow-Up			12 Week Follow-Up
	N	M (SD)	N	M (SD)	d	N	M (SD)	d	N	M (SD)	d
STEP-1 (Sleep Education)
Insomnia Severity Index	51	17.08 (3.44)	51	11.20 (5.50)^***	1.18	26^a	6.85 (3.87)^***	1.62	23^a	6.09 (3.58)^***	2.2
POMS-SF
Total Mood Disturbance	45	14.76 (17.74)	45	8.00 (16.23)^**	0.50
Anger Hostility	47	2.87 (2.78)	47	2.30 (2.58)	0.18
Confusion Bewilderment	54	3.63 (3.29)	47	3.15 (3.70)^**	0.41
Depression Dejection	47	2.19 (3.42)	47	1.51 (1.82)	0.26
Fatigue Inertia	55	9.62 (4.92)	47	6.62 (4.70)^***	0.66
Tension Anxiety	55	5.40 (4.64)	47	4.45 (3.69)^*	0.31
Vigor Activity	54	9.15 (3.97)	47	9.96 (4.36)^*	0.36
STEP-2 (Group CBT-I)
Insomnia Severity Index	14	16.86 (5.14)	14	8.79 (4.58)^***	2.02	14	9.5 (3.35)^***	1.53
POMS-SF
Total Mood Disturbance	14	15.79 (17.11)	13	5.31 (10.16)	0.49	14	7.71(10.59)^*	0.74
Anger Hostility	14	2.50 (2.35)	14	2.43 (1.95)	0.03	14	2.36 (1.74)	0.06
Confusion Bewilderment	14	3.29 (4.08)	13	1.77 (1.59)	0.29	14	2.50 (3.39)	0.26
Depression Dejection	14	2.21 (2.99)	14	1.50 (1.79)	0.34	14	0.86 (0.77)	0.50
Fatigue Inertia	14	9.43 (5.71)	14	6.00 (3.64)^*	0.65	14	6.86 (5.28)^*	0.74
Tension Anxiety	14	5.14 (3.01)	14	3.86 (3.09)	0.53	14	3.14 (2.35)^*	0.71
Vigor Activity	14	6.79 (4.64)	14	8.71 (3.69)^*	0.76	14	8.00 (4.47)	0.41

p < .05,

^**

p < .01,

^***

p < .001

Paired t tests comparing follow up assessments with baseline assessments.

Only participants remitted at STEP-1 4-week follow-up completed the ISI at 8- and 12-weeks after STEP-1; non-remitted participants were referred to STEP-2.